BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,505 | -1.7% | 4,165 | -2.3% | 0.00% | 0.0% |
| Q2 2023 | $460,340 | -9.7% | 4,265 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $509,887 | -17.0% | 4,093 | +0.1% | 0.00% | -33.3% |
| Q4 2022 | $614,126 | +13.9% | 4,088 | +2.4% | 0.00% | 0.0% |
| Q3 2022 | $539,000 | +239.0% | 3,994 | +274.0% | 0.00% | +200.0% |
| Q2 2022 | $159,000 | -6.5% | 1,068 | +6.9% | 0.00% | 0.0% |
| Q1 2022 | $170,000 | -36.6% | 999 | -3.8% | 0.00% | -50.0% |
| Q4 2021 | $268,000 | 0.0% | 1,039 | +5.7% | 0.00% | 0.0% |
| Q3 2021 | $268,000 | +27.6% | 983 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $210,000 | +107.9% | 937 | +1.1% | 0.00% | +100.0% |
| Q1 2021 | $101,000 | +206.1% | 927 | +131.8% | 0.00% | – |
| Q4 2020 | $33,000 | +560.0% | 400 | +433.3% | 0.00% | – |
| Q3 2020 | $5,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |